8-K filing — CHAMPIONS ONCOLOGY, INC. (CSBR)
Filed: 2026-07-27 AccNo: 0001628280-26-049822 Size: 417 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Read original at edgarStocks · News reference
Champions Oncology Q4 Adj. EPS $0.01 Beats $(0.05) Estimate, Sales $13.835M Beat $12.886M Estimate
Champions Oncology (NASDAQ:CSBR) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate of $(0.05) by 120 percent. This is a 114.29 percent increase over losses of $(0.07) per share
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Jul 27, 2026, 8:07 PM
- Checked
- Jul 27, 2026, 8:07 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading